Navigating the Sunshine State of Compliance: A Deep Dive into South Dakota Healthcare Regulations

2026-07-14

South Dakota's healthcare regulatory landscape, a blend of traditional values and growing digital adoption, presents unique opportunities and compliance complexities. This comprehensive guide dissects the state's corporate practice of medicine laws, evolving telehealth rules, controlled substance regulations, and more, offering a critical roadmap for any healthcare entity looking to expand or operate within the Mount Rushmore State.

The vast, open landscapes of South Dakota might evoke an image of simplicity, but its healthcare regulatory environment is anything but. For telehealth founders, national practice owners, compliance officers, and investors, understanding the intricacies of South Dakota's compliance framework is paramount to sustainable and compliant operation. While often overshadowed by larger states, South Dakota is a state on the move, witnessing significant growth in healthcare innovation, particularly in digital health. However, this progress is underpinned by stringent rules, particularly concerning corporate practice of medicine, provider supervision, and controlled substance management. Navigating these requires a precise, data-driven approach – precisely what TrueEval is here to provide.

> For more on this topic, see our analysis: [Navigating the First State: A Comprehensive Compliance Guide for Healthcare Operations in Delaware](/blog/delaware-healthcare-compliance-guide).

The Bedrock: Corporate Practice of Medicine (CPOM) in South Dakota

South Dakota maintains a clear and restrictive stance on the Corporate Practice of Medicine (CPOM), a doctrine designed to prevent corporations or other lay entities from influencing the professional judgment of licensed medical practitioners. Under SD Codified Laws § 36-4-10, only licensed individuals or professional entities owned by licensed individuals are permitted to practice medicine. This means that a standard for-profit corporation, owned by non-physicians, cannot directly employ physicians or other licensed healthcare providers to deliver medical services.

> For more on this topic, see our analysis: [Navigating the First State: A Comprehensive Compliance Guide for Healthcare Operations in Delaware](/blog/delaware-healthcare-compliance-guide).

Key Implications: * Lay Ownership Prohibition: A non-physician or non-licensed entity cannot own a medical practice that employs physicians or dictates clinical decisions. * Fee-Splitting: The direct or indirect sharing of professional fees with unlicensed individuals or entities is generally prohibited. This prevents arrangements where a non-medical entity profits directly from the medical services rendered by a licensed professional. * Control over Clinical Judgment: The core of CPOM is to ensure that medical decisions remain solely with the licensed provider, free from commercial influence. Any arrangement that appears to compromise this autonomy is at high risk of scrutiny.

Given these restrictions, the Management Service Organization (MSO) model is the predominant compliant structure for non-clinical investors or entities seeking to support and grow healthcare practices in South Dakota. An MSO provides administrative, non-clinical support (e.g., billing, marketing, IT, real estate) to a physician-owned professional entity, which retains all clinical control and decision-making authority. It is imperative that the MSO agreement clearly delineates the separation of powers, ensuring that the MSO does not exert control over clinical operations or engage in prohibited fee-splitting. Missteps here can lead to severe penalties, including license revocation and fines.

Navigating the Digital Frontier: South Dakota Telehealth Regulations

South Dakota has demonstrated a commitment to integrating telehealth into its healthcare delivery system, particularly accelerated by the recent public health emergency. SDCL § 36-4-8.3 defines telehealth as the use of electronic information and communication technologies to provide healthcare services to an enrolled patient at an originating site and a healthcare professional at a distant site.

Critical Telehealth Provisions: * Establishment of Patient-Provider Relationship: For telehealth services, a valid patient-provider relationship must be established. This can occur through: * An in-person physical examination. * A previously established relationship between the patient and the healthcare professional, or with another healthcare professional within the same practice group. * An appropriate telehealth encounter utilizing synchronous audiovisual technology capable of creating a clear, two-way, real-time audio and visual communication. * Informed Consent: Healthcare professionals providing telehealth services must obtain appropriate informed consent from the patient, ensuring they understand the nature of telehealth, its limitations, and privacy considerations. * Standard of Care: Crucially, telehealth services rendered in South Dakota must adhere to the same standard of care that would apply to an in-person encounter. This means the quality and appropriateness of care cannot be compromised due to the remote nature of the service. * Reimbursement Parity: A significant development for telehealth providers in South Dakota is the mandate for payment parity. As of January 1, 2021, SDCL § 58-18-87 requires health insurers to reimburse for telehealth services at the same rate as comparable in-person services. This significantly improves the financial viability of telehealth models in the state. * Interstate Medical Licensure Compact (IMLC): South Dakota is a member of the IMLC, which streamlines the process for physicians to obtain licenses in multiple participating states. This is a considerable advantage for telehealth platforms looking to expand physician networks efficiently.

Licensure and Collaborative Practice: The Provider Landscape

Operating in South Dakota necessitates a thorough understanding of state-specific licensing and supervision requirements for various healthcare professionals.

1. Physicians (MDs/DOs): * Must be licensed by the South Dakota Board of Medical and Osteopathic Examiners. * The IMLC simplifies multi-state licensure, but an active South Dakota license is non-negotiable for treating patients within the state's borders.

2. Physician Assistants (PAs): * PAs require licensure by the South Dakota Board of Medical and Osteopathic Examiners. * Collaborative Agreements: PAs operate under a collaborative agreement with a supervising physician. SDCL § 36-4A-11 outlines these requirements, emphasizing that the supervising physician is responsible for the overall medical care provided by the PA. The agreement must clearly define the scope of practice, supervision methods, and protocols for consultation and referral.

3. Advanced Practice Registered Nurses (APRNs): * APRNs (including Certified Nurse Practitioners, Clinical Nurse Specialists, Certified Nurse Midwives, and Certified Registered Nurse Anesthetists) are licensed by the South Dakota Board of Nursing. * Scope of Practice and Collaboration: South Dakota has progressed towards greater autonomy for APRNs, particularly CNPs. However, for certain activities, especially prescribing Schedule II controlled substances, a collaborative agreement or protocol with a physician remains a requirement. The specific nuances depend on the APRN's specialty and experience, as well as the drug schedule. Practices must ensure these agreements are robust, current, and precisely reflect the actual working relationship and responsibilities.

Prescribing Protocols: Controlled Substances in South Dakota

Controlled substance prescribing is one of the most heavily regulated areas of healthcare practice, and South Dakota aligns with federal mandates while adding its own layers of oversight.

1. Prescription Drug Monitoring Program (PDMP): * South Dakota operates a PDMP under SDCL § 34-20E. Prescribers and dispensers are generally mandated to query the PDMP before prescribing or dispensing Schedule II opioids and benzodiazepines. This check is required at least annually for ongoing prescriptions and prior to initial prescription for these specific drug classes. Compliance with PDMP queries is crucial for avoiding disciplinary action and mitigating diversion risks.

2. Telehealth Prescribing of Controlled Substances: * The federal Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation before a practitioner may prescribe controlled substances via the internet. During the COVID-19 Public Health Emergency (PHE), waivers permitted telehealth prescribing of controlled substances without this initial in-person exam. * Current Federal Stance: While the PHE ended, the DEA has issued a temporary rule extending the telehealth prescribing flexibilities for controlled medications through December 31, 2024. This means that, for now, practitioners can continue to prescribe controlled substances via telehealth without a prior in-person visit, provided they meet other federal and state requirements. However, this is a *temporary* measure, and the DEA is working towards a permanent rule. Practices must stay exceptionally vigilant for the final rule, which may reinstate or modify the in-person requirement. * State Alignment: SDCL § 36-4-8.3(7) states that a prescription for a controlled substance may be issued without an in-person medical evaluation if done "in accordance with federal and state laws and rules." This indicates South Dakota's alignment with federal guidance, underscoring the importance of adhering to current DEA directives regarding telehealth prescribing.

3. Critical Warning: 7-Hydroxymitragynine (Kratom Derivatives) and Schedule I Substances: * The DEA has proposed a temporary Schedule I classification for three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16) and is seeking to define a threshold for 7-hydroxymitragynine (7-OH) itself to also be placed in Schedule I. Schedule I substances are federally classified as having a high potential for abuse and no currently accepted medical use in treatment in the United States. * Immediate Action Required: For *all* healthcare businesses, including telehealth brands, medspas, dental practices, and chiropractic offices, this is a critical impact. If these substances (often found in products derived from *Mitragyna speciosa*, or kratom, or synthetic alternatives) are temporarily or permanently placed into Schedule I, handling, prescribing, dispensing, or even recommending them becomes subject to the most severe federal regulatory controls and criminal sanctions under the CSA. Practices must conduct immediate reviews of any products, supplements, or compounds they may be utilizing or recommending to ensure they do not contain these specific substances. Non-compliance could lead to severe legal and financial repercussions, including federal charges and license revocation. Vigilance is paramount to avoid inadvertent violations.

Enforcement and Risk Mitigation: Lessons from the Plains

While South Dakota may not generate the volume of enforcement actions seen in states like California or New York, the regulatory bodies, particularly the Board of Medical and Osteopathic Examiners, are active and thorough. Disciplinary actions often highlight key areas of focus:

Standard of Care Violations: Failure to meet the established standard of care, whether in diagnosis, treatment, or patient management, is a consistent ground for disciplinary action.
Inadequate Recordkeeping: Poor, incomplete, or fraudulent medical records are a frequent trigger for board investigations. Comprehensive and accurate documentation is critical, especially for telehealth encounters.
Controlled Substance Mismanagement: Violations related to PDMP checks, over-prescribing, diversion, or improper prescribing via telehealth (especially if federal waivers lapse) are severely penalized.
Unprofessional Conduct: This broad category can include anything from ethical breaches to engaging in practice while impaired.

Key Compliance Pitfalls and How to Avoid Them: 1. CPOM Violations: The most common mistake for new entrants is failing to structure operations compliantly under South Dakota's CPOM doctrine. Always operate via a robust MSO model, ensuring clear segregation of clinical and administrative functions. 2. Licensure Gaps: Assuming multi-state compacts cover all scenarios or delaying South Dakota licensure. Every provider treating a South Dakota patient must hold a valid South Dakota license. 3. PDMP Non-Compliance: Failing to integrate mandatory PDMP checks into prescribing workflows. This is easily trackable and a common enforcement target. 4. Telehealth Relationship Failures: Prescribing or treating without properly establishing a patient-provider relationship as required by SDCL § 36-4-8.3. 5. Inadequate Supervision/Collaboration: For PAs and APRNs, ensure collaborative agreements are specific, current, and accurately reflect the delegated responsibilities and supervision protocols. Regular review and updates are essential. 6. Controlled Substance Missteps (Especially New Listings): Prescribing or recommending newly scheduled substances like 7-hydroxymitragynine-related compounds will result in immediate and severe federal and state enforcement actions. Stay informed of DEA and HHS updates.

South Dakota in Regional Context: A Quick Comparison

Compared to its immediate neighbors, South Dakota's regulatory environment shares many similarities, particularly regarding CPOM and telehealth:

North Dakota, Nebraska, Iowa, Montana, Wyoming: These states generally maintain prohibitions on the Corporate Practice of Medicine, similar to South Dakota. This means the MSO model is a common and necessary compliance strategy across much of the upper Midwest and Mountain West.
Telehealth Evolution: All these neighboring states have also made strides in telehealth adoption, often with reimbursement parity mandates and clear definitions for patient-provider relationships. Many, including North Dakota, Nebraska, Iowa, Montana, and Wyoming, are also members of the Interstate Medical Licensure Compact, facilitating physician mobility.

While there's a regional trend towards supportive telehealth policies and consistent CPOM restrictions, the granular details—like specific APRN scope of practice, PDMP mandates, and even nuances in telehealth patient relationship establishment—can vary. This underscores the critical need for state-specific compliance analysis rather than a blanket regional approach.

What This Means For Your Practice: A TrueEval Roadmap

For any healthcare business considering operations or expansion in South Dakota, a proactive and detailed compliance strategy is not merely advisable – it is imperative for safeguarding your practice and ensuring long-term success.

Robust MSO Structure: For any lay-owned entity, establishing a legally sound and operationally distinct MSO is your foundational step. Ensure that the physician-owned professional entity maintains absolute clinical control.
Licensure Verification: Implement rigorous processes for verifying and maintaining all necessary state licenses for every provider rendering services to South Dakota patients, leveraging the IMLC where applicable for physicians.
Telehealth Protocol Adherence: Train providers extensively on South Dakota's specific requirements for establishing patient-provider relationships via telehealth and obtaining informed consent. Documentation must reflect compliance.
Controlled Substance Vigilance: Develop and enforce strict protocols for PDMP checks. Most critically, stay abreast of all DEA and HHS updates regarding controlled substances, particularly new Schedule I classifications like the 7-hydroxymitragynine compounds. Any involvement with such substances after scheduling will have dire consequences.
Collaborative Agreement Review: Regularly review and update all collaborative practice agreements for PAs and APRNs, ensuring they accurately reflect current regulations and actual practice.
Continuous Monitoring: The regulatory landscape is dynamic. Partner with experts or leverage sophisticated compliance infrastructure like TrueEval to continuously monitor changes at both federal and state levels, especially concerning telehealth and controlled substance prescribing.

South Dakota offers fertile ground for healthcare innovation, particularly in telehealth. By proactively addressing its unique regulatory demands, healthcare businesses can not only comply with the law but also build a trusted, sustainable presence in the heart of the Great Plains.